# AstraZeneca Pharmaceuticals LP – FDA Inspection, May 31, 2024

Source: https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/f4d9b1b5-b5fa-492a-8363-3e39782013b0
Source feed: FDA_Inspections

> FDA inspection 1238346 of AstraZeneca Pharmaceuticals LP, May 31, 2024. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. 15 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1238346
- Company Name: AstraZeneca Pharmaceuticals LP
- Inspection Date: 2024-05-31
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1299436 - 2026-01-14
- [FDA Inspection 1254239 - 2024-10-25](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/da96b405-5d6f-462e-8164-cc589345ae2e)
- FDA Inspection 1230136 - 2024-01-22
- FDA Inspection 1211604 - 2023-07-18
- FDA Inspection 1157291 - 2021-09-30

## Related Officers

- [Investigator](https://www.keypedia.com/people/ekaterina-allen/760a7817-8e5b-45f9-82ee-db6ca139a92e)
- [Issuing Officer](https://www.keypedia.com/people/james-r-birkenstamm/eb1192a4-3c76-4243-886c-9b5805871ad1)
- [Jazmine N. Brown](https://www.keypedia.com/people/jazmine-n-brown/194fc53f-942f-4e8c-a475-b7eac11be103)

Company: https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/f2e34b74-3ef4-4f39-8f6f-41eceb3bb779

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c